Opportunities in Pharmacometrics at Eli Lilly and Company

From: Michael A Heathman Date: April 11, 2013 job Source: mail-archive.com
Eli Lilly and Company is seeking creative, motivated scientists to join our Global Pharmacometrics group. Two Indianapolis-based positions are currently available. Requisition ID: 2345BR Position Title: Research Scientist Location: Lilly Corporate Center, Indianapolis Basic Qualifications: PhD or equivalent in Pharmacokinetics, Pharmaceutical Sciences, Biostatistics, Biomedical Engineering, or related discipline. A minimum of 3 years experience with PK/PD modeling and Pharmacometric software tools. Key Deliverables: Implement modeling and simulation strategies in accordance with project needs. Develop PK/PD and drug-disease models to support all phases of drug development. Conduct trial simulations to support study optimization and dosing recommendations in all phases of development. Interpret and present modeling and simulation results to cross-functional project teams. Requisition ID: 2344BR Position Title: Principal Research Scientist Location: Lilly Corporate Center, Indianapolis Basic Qualifications: PhD or equivalent in Pharmacokinetics, Pharmaceutical Sciences, Biostatistics, Biomedical Engineering, or related discipline. A minimum of 10 years experience with PK/PD modeling and Pharmacometric software tools. Key Deliverables: Plan, implement, and critically review modeling and simulation strategies in accordance with project needs. Develop PK/PD and drug-disease models to support all phases of drug development. Conduct trial simulations to support study optimization and dosing recommendations in all phases of development. Interpret and present modeling and simulation results to cross-functional project teams and regulatory agencies. Lead projects and interact with cross-functional teams to deliver results under tight timelines. Responsible for preparation of documents for regulatory submission and communication. Interested individuals may apply at http://www.lilly.com/careers. Michael Heathman Group Leader, Global Pharmacometrics Eli Lilly and Company